TWD 27.65
(-3.49%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 13.09 Million TWD | -16.97% |
2022 | 15.76 Million TWD | 256.74% |
2021 | 4.42 Million TWD | 0.0% |
2020 | - TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 11.23 Million TWD | -7.68% |
2024 Q1 | 12.16 Million TWD | -7.05% |
2023 Q4 | 13.09 Million TWD | 0.15% |
2023 FY | 13.09 Million TWD | -16.97% |
2023 Q3 | 13.07 Million TWD | -6.39% |
2023 Q2 | 13.96 Million TWD | -6.08% |
2023 Q1 | 14.87 Million TWD | 326.69% |
2022 Q4 | 3.48 Million TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 8.925% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 96.861% |
Visgeneer Inc. | 158.6 Million TWD | 91.746% |
Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 95.384% |
Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -1404.828% |
Sagittarius Life Science Corp | 13.32 Million TWD | 1.734% |
NaviFUS Corp. | 32.69 Million TWD | 59.955% |
Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -2333.457% |
TaiRx, Inc. | 12.28 Million TWD | -6.56% |
Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 51.727% |
Lin BioScience, Inc. | 42.87 Million TWD | 69.463% |
TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -1018.019% |
Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | -3.822% |
Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -846.638% |
BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 77.507% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 96.749% |
Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 92.48% |
RBC Bioscience Corporation | 487.36 Million TWD | 97.314% |
Bio Preventive Medicine Corp. | 113.44 Million TWD | 88.46% |
Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 98.08% |
G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -141.061% |
AP Biosciences Inc | 82.07 Million TWD | 84.05% |
EirGenix Inc. | 465.16 Million TWD | 97.186% |
Enimmune corporation | 45.73 Million TWD | 71.374% |
Lukas Biomedical Inc. | 82.55 Million TWD | 84.141% |
GlycoNex Incorporation | 900 Thousand TWD | -1354.667% |
BRIM Biotechnology, Inc. | 3.59 Million TWD | -264.477% |
Level Biotechnology Inc. | 13.5 Million TWD | 3.037% |
Pharmosa Biopharm Inc. | 144.36 Million TWD | 90.932% |
TaiMed Biologics Inc. | 750.85 Million TWD | 98.256% |
Mycenax Biotech Inc. | 726.27 Million TWD | 98.197% |
SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -519.3% |
Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -200.689% |
Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 95.91% |
Feng Chi Biotech Corp. | 10.79 Million TWD | -21.245% |
NeoCore Technology Co., Ltd. | 96.89 Million TWD | 86.488% |
TWi Biotechnology, Inc. | 7.97 Million TWD | -64.245% |
Neith Corporation | 3.54 Million TWD | -269.726% |
Sunny Pharmtech Inc. | 391.42 Million TWD | 96.655% |
VBI | - TWD | -Infinity% |
BiOptic Inc. | 93.19 Million TWD | 85.952% |
Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -121.974% |
Sinew Pharma Inc. | 6.46 Million TWD | -102.537% |
Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 93.325% |
GeneReach Biotechnology Corp. | 257.03 Million TWD | 94.907% |
CHO Pharma, Inc. | - TWD | -Infinity% |
Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.55% |
3D Global Biotech Inc. | 10.37 Million TWD | -26.139% |
Senhwa Biosciences, Inc. | 9.6 Million TWD | -36.361% |
Intech Biopharm Corporation | 1.43 Billion TWD | 99.088% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 96.71% |
TCI GENE Inc. | 6.79 Million TWD | -92.671% |
MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -57.394% |
Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 95.126% |
NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -22.561% |
PharmaEngine, Inc. | 14.8 Million TWD | 11.594% |
Savior Lifetec Corporation | 270.37 Million TWD | 95.158% |
TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 82.471% |
OBI Pharma, Inc. | 501.05 Million TWD | 97.387% |
Meribank Biotech Co., Ltd | 34.03 Million TWD | 61.538% |
Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.337% |
Acepodia, Inc. | 273.81 Million TWD | 95.219% |
Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 36.005% |